{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:07:58Z","timestamp":1789834078617,"version":"4.0.1"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Institution of Quality of Life in Cancer"},{"name":"Samsung Fire & Marine Insurance"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Prior research on colorectal cancer (CRC) risk in RA lacked analyses incorporating cardiometabolic or behavioural factors, offered limited subsite-specific data and did not consider RA serostatus. This study assessed the association between RA and subsite-specific CRC risk by RA serostatus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using the Korean National Health Insurance System database, we identified 40\u2009909 patients with newly diagnosed RA between 2010 and 2017, matched by age and sex at a 1:5 ratio with 204\u2009545 non-RA participants. Multivariable Cox regression models were used to estimate hazard ratio (HR) for the association between RA and CRC incidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During a median follow-up of 5.3\u2009years, 2174 subjects (319 with RA and 1855 controls) were diagnosed with CRC. Patients with RA had a decreased risk for CRC compared with non-RA participants (HR, 0.89; 95% CI, 0.79\u20130.99). A decreased risk of CRC was found in patients with seronegative RA (HR, 0.79; 95% CI, 0.63\u20130.98) but not in those with seropositive RA (HR, 0.93; 95% CI, 0.81\u20131.06). The inverse association between RA and CRC was significant for rectal cancer (HR, 0.63; 95% CI, 0.45\u20130.87) but not for proximal (HR, 1.04; 95% CI, 0.79\u20131.39) or distal colon cancer (HR, 0.84; 95% CI, 0.64\u20131.11). The inverse association between RA and CRC risk was more pronounced in women (HR, 0.80; 95% CI, 0.69\u20130.94; P for interaction\u2009=\u20090.043).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our analyses provide solid evidence of an inverse association between RA and CRC risk, particularly in patients with seronegative RA, rectal cancer cases and women.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaf451","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T11:35:35Z","timestamp":1755948935000},"source":"Crossref","is-referenced-by-count":2,"title":["RA and risk of colorectal cancer: a nationwide cohort study"],"prefix":"10.1093","volume":"65","author":[{"given":"Keun Hye","family":"Jeon","sequence":"first","affiliation":[{"name":"Department of Family Medicine, CHA Gumi Medical Center, CHA University School of Medicine , Gumi,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhyung","family":"Jung","sequence":"additional","affiliation":[{"name":"Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine , Suwon,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3705-0285","authenticated-orcid":false,"given":"Mi Hee","family":"Cho","sequence":"additional","affiliation":[{"name":"Samsung C&T Medical Clinic, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine , Seoul,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagyeong","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Hallym University Dongtan Sacred Heart Hospital , Hwaseong,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6096-1263","authenticated-orcid":false,"given":"Kyungdo","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Statistics and Actuarial Science, Soongsil University , Seoul,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Young","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Family Medicine\/Supportive Care Center, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul,","place":["Republic of Korea"]},{"name":"Department of Clinical Research Design and Evaluation, Samsung Advanced Institute for Health Science and Technology (SAIHST), Sungkyunkwan University , Seoul,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8128-8920","authenticated-orcid":false,"given":"Dong Wook","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Family Medicine\/Supportive Care Center, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul,","place":["Republic of Korea"]},{"name":"Department of Clinical Research Design and Evaluation, Samsung Advanced Institute for Health Science and Technology (SAIHST), Sungkyunkwan University , Seoul,","place":["Republic of Korea"]},{"name":"Center for Trend Monitoring-Risk Modeling, Institution of Quality of Life in Cancer, Samsung Medical Center , Seoul,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"2026020205374506600_keaf451-B1","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet (London, England)"},{"key":"2026020205374506600_keaf451-B2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3390\/jcm10030509","article-title":"The key comorbidities in patients with rheumatoid arthritis: a narrative review","volume":"10","author":"Taylor","year":"2021","journal-title":"J Clin Med"},{"key":"2026020205374506600_keaf451-B3","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.3390\/cancers15225441","article-title":"Solid cancers and rheumatoid arthritis","volume":"15","author":"Kalliolias","year":"2023","journal-title":"Cancers"},{"key":"2026020205374506600_keaf451-B4","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13075-015-0728-9","article-title":"Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis","volume":"17","author":"Simon","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"2026020205374506600_keaf451-B5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1001\/jamaoncol.2016.4227","article-title":"Prognostic survival associated with left-sided vs right-sided colon cancer: a systematic review and meta-analysis","volume":"3","author":"Petrelli","year":"2017","journal-title":"JAMA Oncol"},{"key":"2026020205374506600_keaf451-B6","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.3390\/ijms19092577","article-title":"Are colon and rectal cancer two different tumor entities? A proposal to abandon the term colorectal cancer","volume":"19","author":"Paschke","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2026020205374506600_keaf451-B7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1053\/j.gastro.2020.03.054","article-title":"Risk factor profiles differ for cancers of different regions of the colorectum","volume":"159","author":"Wang","year":"2020","journal-title":"Gastroenterology"},{"key":"2026020205374506600_keaf451-B8","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3899\/jrheum.140533","article-title":"Incidence of malignancy and the risk of lymphoma in Japanese patients with rheumatoid arthritis compared to the general population","volume":"42","author":"Hashimoto","year":"2015","journal-title":"J Rheumatol"},{"key":"2026020205374506600_keaf451-B9","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/rheumatology\/ken130","article-title":"Cancer risk in hospitalized rheumatoid arthritis patients","volume":"47","author":"Hemminki","year":"2008","journal-title":"Rheumatology (Oxford, England)"},{"key":"2026020205374506600_keaf451-B10","first-page":"69","article-title":"When autoantibodies are missing: the challenge of seronegative rheumatoid arthritis","volume":"12","author":"Paroli","year":"2023","journal-title":"Antibodies (Basel, Switzerland)"},{"key":"2026020205374506600_keaf451-B11","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/mr\/roac085","article-title":"Trends in risks of malignancies in Japanese patients with rheumatoid arthritis: analyses from a 14-year observation of the IORRA cohort","volume":"33","author":"Sugimoto","year":"2023","journal-title":"Modern Rheumatol"},{"key":"2026020205374506600_keaf451-B12","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00296-014-2982-6","article-title":"No overall increased risk of cancer in patients with rheumatoid arthritis: a nationwide dynamic cohort study in Taiwan","volume":"34","author":"Huang","year":"2014","journal-title":"Rheumatol Int"},{"key":"2026020205374506600_keaf451-B13","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/art.30134","article-title":"The risk of cancer in patients with rheumatoid arthritis: a nationwide cohort study in Taiwan","volume":"63","author":"Chen","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2026020205374506600_keaf451-B14","first-page":"1001","article-title":"Risk of cancer among rheumatoid arthritis patients in California","volume":"20","author":"Parikh-Patel","year":"2009","journal-title":"Cancer Causes Control: CCC"},{"key":"2026020205374506600_keaf451-B15","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1136\/ard.2004.033993","article-title":"Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists","volume":"64","author":"Askling","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2026020205374506600_keaf451-B16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/1097-0215(20001101)88:3<497::AID-IJC27>3.0.CO;2-J","article-title":"Risk of malignancy among patients with rheumatic conditions","volume":"88","author":"Thomas","year":"2000","journal-title":"Int J Cancer"},{"key":"2026020205374506600_keaf451-B17","article-title":"Rheumatoid arthritis and cancer risk in the Million Women Study","volume":"53","author":"Yang","year":"2024","journal-title":"Int J Epidemiol"},{"key":"2026020205374506600_keaf451-B18","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3390\/jpm12060965","article-title":"Potential cancer risk in patients with rheumatoid arthritis: a longitudinal korean population-based analysis","volume":"12","author":"Choi","year":"2022","journal-title":"J Pers Med"},{"key":"2026020205374506600_keaf451-B19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.23838\/pfm.2021.00135","article-title":"National General Health Screening Program in Korea: history, current status, and future direction","volume":"6","author":"Shin","year":"2022","journal-title":"Precis Future Med"},{"key":"2026020205374506600_keaf451-B20","first-page":"799","article-title":"Data resource profile: the National Health Information Database of the National Health Insurance Service in South Korea","volume":"46","author":"Cheol Seong","year":"2017","journal-title":"Int J Epidemiol"},{"key":"2026020205374506600_keaf451-B21","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1007\/s00296-013-2833-x","article-title":"Development of an algorithm for identifying rheumatoid arthritis in the Korean National Health Insurance claims database","volume":"33","author":"Cho","year":"2013","journal-title":"Rheumatol Int"},{"key":"2026020205374506600_keaf451-B22","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1093\/rheumatology\/keaf103","article-title":"Urological cancer risk in patients with rheumatoid arthritis compared to matched controls: a nationwide cohort study","volume":"64","author":"Lee","year":"2025","journal-title":"Rheumatology (Oxford, England)"},{"key":"2026020205374506600_keaf451-B23","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41375-024-02477-3","article-title":"Rheumatoid arthritis and the risk of hematologic malignancies: a nationwide cohort study","volume":"39","author":"Cho","year":"2025","journal-title":"Leukemia"},{"key":"2026020205374506600_keaf451-B24","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3961\/jpmph.23.033","article-title":"Operational definitions of colorectal cancer in the Korean National Health Insurance database","volume":"56","author":"Park","year":"2023","journal-title":"J Prevent Med Public Health = Yebang Uihakhoe chi"},{"key":"2026020205374506600_keaf451-B25","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4143\/crt.2021.044","article-title":"Validation of cancer diagnosis based on the National Health Insurance Service Database versus the National Cancer Registry Database in Korea","volume":"54","author":"Yang","year":"2022","journal-title":"Cancer Res Treat"},{"key":"2026020205374506600_keaf451-B26","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1200\/JCO.22.01895","article-title":"Sex and tumor-site differences in the association of alcohol intake with the risk of early-onset colorectal cancer","volume":"41","author":"Jin","year":"2023","journal-title":"J Clin Oncol"},{"key":"2026020205374506600_keaf451-B27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13075-021-02671-z","article-title":"Unraveling heterogeneity within ACPA-negative rheumatoid arthritis: the subgroup of patients with a strong clinical and serological response to initiation of DMARD treatment favor disease resolution","volume":"24","author":"Verstappen","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"2026020205374506600_keaf451-B28","doi-asserted-by":"crossref","first-page":"e0195550","DOI":"10.1371\/journal.pone.0195550","article-title":"Clinical management of seronegative and seropositive rheumatoid arthritis: a comparative study","volume":"13","author":"Choi","year":"2018","journal-title":"PloS One"},{"key":"2026020205374506600_keaf451-B29","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.3899\/jrheum.140082","article-title":"Prognosis of seronegative patients in a large prospective cohort of patients with early inflammatory arthritis","volume":"41","author":"Barra","year":"2014","journal-title":"J Rheumatol"},{"key":"2026020205374506600_keaf451-B30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2026020205374506600_keaf451-B31","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/acr.24596","article-title":"2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis","volume":"73","author":"Fraenkel","year":"2021","journal-title":"Arthritis Care Res"},{"key":"2026020205374506600_keaf451-B32","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.canep.2018.11.002","article-title":"Non-aspirin non-steroidal anti-inflammatory drugs in prevention of colorectal cancer in people aged 40 or older: a systematic review and meta-analysis","volume":"58","author":"Tomi\u0107","year":"2019","journal-title":"Cancer Epidemiol"},{"key":"2026020205374506600_keaf451-B33","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1158\/1078-0432.CCR-13-1573","article-title":"NSAIDs inhibit tumorigenesis, but how?","volume":"20","author":"Gurpinar","year":"2014","journal-title":"Clin Cancer Res"},{"key":"2026020205374506600_keaf451-B34","doi-asserted-by":"crossref","first-page":"100768","DOI":"10.1016\/j.lanepe.2023.100768","article-title":"Risk of cancer for patients with rheumatoid arthritis versus general population: a national claims database cohort study","volume":"35","author":"Beydon","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"2026020205374506600_keaf451-B35","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.cgh.2018.07.030","article-title":"Heterogeneity of colorectal cancer risk factors by anatomical subsite in 10 European countries: a multinational cohort study","volume":"17","author":"Murphy","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026020205374506600_keaf451-B36","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.3748\/wjg.v21.i17.5167","article-title":"Sex- and gender-specific disparities in colorectal cancer risk","volume":"21","author":"Kim","year":"2015","journal-title":"World J Gastroenterol"},{"key":"2026020205374506600_keaf451-B37","doi-asserted-by":"crossref","first-page":"e23196","DOI":"10.1371\/journal.pone.0023196","article-title":"Site-specific risk factors for colorectal cancer in a Korean population","volume":"6","author":"Shin","year":"2011","journal-title":"PloS One"},{"key":"2026020205374506600_keaf451-B38","doi-asserted-by":"crossref","first-page":"d1584","DOI":"10.1136\/bmj.d1584","article-title":"Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study","volume":"342","author":"Sch\u00fctze","year":"2011","journal-title":"BMJ (Clinical Res Ed)"},{"key":"2026020205374506600_keaf451-B39","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1001\/jama.2022.18324","article-title":"Hormone therapy for the primary prevention of chronic conditions in postmenopausal persons: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"328","author":"Gartlehner","year":"2022","journal-title":"JAMA"},{"key":"2026020205374506600_keaf451-B40","doi-asserted-by":"crossref","first-page":"580.e1","DOI":"10.1016\/j.ajog.2017.02.002","article-title":"Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners\u2019 Oral Contraception Study","volume":"216","author":"Iversen","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"2026020205374506600_keaf451-B41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(18)31133-4","article-title":"Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials","volume":"392","author":"Rothwell","year":"2018","journal-title":"Lancet (London, England)"},{"key":"2026020205374506600_keaf451-B42","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S2468-1253(21)00426-X","article-title":"The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection","volume":"7","author":"Patel","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026020205374506600_keaf451-B43","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3393\/ac.2018.08.02.1","article-title":"Characteristics and survival of Korean patients with colorectal cancer based on data From the Korea Central Cancer Registry Data","volume":"34","author":"Hur","year":"2018","journal-title":"Ann Coloproctol"},{"key":"2026020205374506600_keaf451-B44","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.4143\/crt.2022.1612","article-title":"Right then, wrong now: early-onset colorectal cancer in Korea","volume":"55","author":"Shin","year":"2023","journal-title":"Cancer Res Treat"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf451\/64130299\/keaf451.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/1\/keaf451\/64130299\/keaf451.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/1\/keaf451\/64130299\/keaf451.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T10:38:01Z","timestamp":1770028681000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/doi\/10.1093\/rheumatology\/keaf451\/8241051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,8]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf451","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,8,26]]},"article-number":"keaf451"}}